NCT06003231 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06003231
Title	A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	Seagen Inc.
Indications	endometrial adenocarcinoma hypopharynx cancer fallopian tube cancer laryngeal squamous cell carcinoma ovarian cancer head and neck squamous cell carcinoma peritoneum cancer oropharynx cancer lung non-small cell carcinoma oral squamous cell carcinoma
Therapies	Disitamab vedotin
Age Groups:	senior \| adult
Covered Countries	USA \| ITA \| GBR \| ESP \| DEU \| CAN \| AUS

NCT06003231
Clinical Trial Detail